Filing Details

Accession Number:
0001567619-21-019298
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-03 19:13:14
Reporting Period:
2021-11-01
Accepted Time:
2021-11-03 19:13:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770787 10X Genomics Inc. TXG () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189140 R John Stuelpnagel C/O 10X Genomics, Inc.
6230 Stoneridge Mall Road
Pleasanton CA 94588
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2021-11-01 100 $160.33 361,516 No 4 S Direct
Class A Common Stock Disposition 2021-11-01 100 $160.75 361,416 No 4 S Direct
Class A Common Stock Disposition 2021-11-01 100 $161.52 361,316 No 4 S Direct
Class A Common Stock Disposition 2021-11-01 1,494 $163.10 359,822 No 4 S Direct
Class A Common Stock Disposition 2021-11-01 2,906 $163.89 356,916 No 4 S Direct
Class A Common Stock Disposition 2021-11-01 300 $164.58 356,616 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $162.50 to $163.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  3. This transaction was executed in multiple trades at prices ranging from $163.50 to $164.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  4. This transaction was executed in multiple trades at prices ranging from $164.55 to $164.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.